Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk.

MLA

Mehta, Tanvi, et al. “Using Group Testing in a Two-Phase Epidemiologic Design to Identify the Effects of a Large Number of Antibody Reactions on Disease Risk.” BMC Medical Research Methodology, vol. 22, no. 1, Dec. 2022, p. 324. EBSCOhost, https://doi.org/10.1186/s12874-022-01798-0.

APA

Mehta, T., Malinovsky, Y., Abnet, C. C., & Albert, P. S. (2022). Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk. BMC Medical Research Methodology, 22(1), 324. https://doi.org/10.1186/s12874-022-01798-0

Chicago

Mehta, Tanvi, Yaakov Malinovsky, Christian C Abnet, and Paul S Albert. 2022. “Using Group Testing in a Two-Phase Epidemiologic Design to Identify the Effects of a Large Number of Antibody Reactions on Disease Risk.” BMC Medical Research Methodology 22 (1): 324. doi:10.1186/s12874-022-01798-0.